EUVIMEDEUVIMED entdecken
Crossref

Multidisciplinárny konsenzus pre diagnostiku transtyretínovej amyloidovej kardiomyopatie / A multidisciplinary consensus for diagnosis of transthyretin cardiac amyloidosis

Eva Gonçalvesová, Ľubica Harvanová, Marcela Danková, Miroslav Gbúr, Katarína Balážová, Pavol Povinec

Cardiology Letters · 10.11.2026 · 35 (4) · 194-201

DOI: 10.4149/cardiol_2026_4_5_2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Letters, online erschienen am 10.11.2026. Verfasst von Eva Gonçalvesová und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet still underdiagnosed cause of heart failure and arrhythmias, particularly in patients over 65 years with unexplained left ventricular hypertrophy.This multidisciplinary consensus supports the implementation of a standardized diagnostic algorithm for ATTR-CM in Slovakia, aligned with ESC 2023, ACC 2025, WHF 2023 and ASH 2026 recommendations.Early identification of clinical "red flags" and echocardiographic features is essential to suspect and detect echocardiographic features of the disease.Rapid exclusion of light-chain amyloidosis using serum free light chains and serum/urine immunofixation (combined sensitivity 99%) is a critical step.Confirmation of ATTR-CM relies primarily on 99mTc-DPD/HDP scintigraphy with SPECT/CT, where Perugini grade 2-3 uptake in the absence of monoclonal protein allows non-biopsy diagnosis.The document highlights diagnostic pitfalls, including interpretation challenges in monoclonal gammopathy and false-positive or false-negative scintigraphy.Genetic testing is mandatory to distinguish wild-type from variant ATTR, enabling appropriate family screening and treatment decisions.Management combines heart-failure therapy with disease-modifying agents-TTR stabilizers (akoramidis, tafamidis) and TTR synthesis inhibitor (vutrisiran).The diagnostic pathway is summarized in five steps: Suspect -Detect -Exclude -Confirm -Type, aiming to improve early recognition and prognosis of patients with ATTR-CM.Fig. 5, Tab. 1, Ref. 15, on-line full text (Free, PDF), www. cardiologyletters.sk

Zitieren

APA

Gonçalvesová, E., Harvanová, Ľ., Danková, M., Gbúr, M., Balážová, K., & Povinec, P. (2026). Multidisciplinárny konsenzus pre diagnostiku transtyretínovej amyloidovej kardiomyopatie / A multidisciplinary consensus for diagnosis of transthyretin cardiac amyloidosis. Cardiology Letters, 35(4), 194-201. https://doi.org/10.4149/cardiol_2026_4_5_2

Vancouver

Gonçalvesová E, Harvanová Ľ, Danková M, Gbúr M, Balážová K, Povinec P. Multidisciplinárny konsenzus pre diagnostiku transtyretínovej amyloidovej kardiomyopatie / A multidisciplinary consensus for diagnosis of transthyretin cardiac amyloidosis. Cardiology Letters. 2026;35(4):194-201. doi:10.4149/cardiol_2026_4_5_2

BibTeX
@article{Gonalvesov2026,
  author = {Gonçalvesová, Eva and Harvanová, Ľubica and Danková, Marcela and Gbúr, Miroslav and Balážová, Katarína and Povinec, Pavol},
  title = {Multidisciplinárny konsenzus pre diagnostiku transtyretínovej amyloidovej kardiomyopatie / A multidisciplinary consensus for diagnosis of transthyretin cardiac amyloidosis},
  journal = {Cardiology Letters},
  year = {2026},
  volume = {35},
  number = {4},
  pages = {194--201},
  doi = {10.4149/cardiol_2026_4_5_2}
}
Kostenlos starten →